130 related articles for article (PubMed ID: 6730428)
1. Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay.
Urbaniak SJ; Greiss MA; Crawford RJ; Fergusson MJ
Vox Sang; 1984; 46(5):323-9. PubMed ID: 6730428
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
[TBL] [Abstract][Full Text] [Related]
3. Results of tests with different cellular bioassays in relation to severity of RhD haemolytic disease. Report from nine collaborating laboratories.
Vox Sang; 1991; 60(4):225-9. PubMed ID: 1926829
[TBL] [Abstract][Full Text] [Related]
4. Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation.
Garner SF; Wiener E; Contreras M; Nicolini U; Kochenour N; Letsky E; Rodeck CH
Br J Haematol; 1992 Jan; 80(1):97-101. PubMed ID: 1536816
[TBL] [Abstract][Full Text] [Related]
5. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
[TBL] [Abstract][Full Text] [Related]
6. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
[TBL] [Abstract][Full Text] [Related]
7. Antibody dependent cell mediated cytotoxicity and erythrophagocytosis assays in Rh haemolytic disease of the newborn.
Patil JS; Gupte SC
Ceylon Med J; 1996 Jun; 41(2):46-50. PubMed ID: 8771942
[TBL] [Abstract][Full Text] [Related]
8. Misleading results in the determination of haemolytic disease of the newborn using antibody titration and ADCC in a woman with anti-Lub.
Novotny VM; Kanhai HH; Overbeeke MA; Schlaman-Nijp A; Harvey MS; Brand A
Vox Sang; 1992; 62(1):49-52. PubMed ID: 1580067
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of maternal anti-D concentrations during pregnancy.
Filbey D; Berseus O; Sandström B; Wesström G
Early Hum Dev; 1987 Jan; 15(1):1-9. PubMed ID: 3102209
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
[TBL] [Abstract][Full Text] [Related]
11. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
Lockyer WJ
Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
[No Abstract] [Full Text] [Related]
12. Value of maternal anti-D concentration in predicting the outcome of Rh(D) haemolytic disease.
Harrison KL; Baker JW; Popper EI; Harden PA
Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):6-8. PubMed ID: 6430264
[TBL] [Abstract][Full Text] [Related]
13. Rhesus haemolytic disease.
Whittle MJ
Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
[No Abstract] [Full Text] [Related]
14. In vitro assays to predict the severity of hemolytic disease of the newborn.
Hadley AG
Transfus Med Rev; 1995 Oct; 9(4):302-13. PubMed ID: 8541713
[No Abstract] [Full Text] [Related]
15. Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.
Brouwers HA; Overbeeke MA; Ouwehand WH; Keuning K; van Ertbruggen I; van Leeuwen EF; Stoop JW; Engelfriet CP
Br J Haematol; 1988 Dec; 70(4):465-9. PubMed ID: 3219297
[TBL] [Abstract][Full Text] [Related]
16. Antenatal tests in the diagnosis and assessment of severity of haemolytic disease (Hd) of the fetus and newborn (hdn).
Contreras M
Vox Sang; 1994; 67 Suppl 3():207-10. PubMed ID: 7975494
[No Abstract] [Full Text] [Related]
17. [New possibilities in diagnosis of hemolytic diseases in newborns].
Fischer K; Poschmann A; Grundmann A; Asmussen S
Infusionsther Transfusionsmed; 1992 Aug; 19(4):208-13. PubMed ID: 1422082
[TBL] [Abstract][Full Text] [Related]
18. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
Bowell P; Wainscoat JS; Peto TE; Gunson HH
Br Med J (Clin Res Ed); 1982 Jul; 285(6338):327-9. PubMed ID: 6284295
[TBL] [Abstract][Full Text] [Related]
19. [Two neonates with severe rhesus antagonism inspite of low values in recent tests of antibody dependent cellular cytotoxicity (ADCC)].
Janssens LP; Koolen AM; Oei SG; Overbeeke MA
Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1823-6. PubMed ID: 10526587
[TBL] [Abstract][Full Text] [Related]
20. Non-"D" rhesus and irregular antibodies--an approach to management.
Dornan KJ
Ir Med J; 1982 Mar; 75(3):79-82. PubMed ID: 6804410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
